DUBLIN--(BUSINESS WIRE)--The "Small Molecule API Contract Manufacturer Quality Benchmarking (2nd edition)" report has been added to Research and Markets' offering. As pharmaceutical and ...

DUBLIN--(BUSINESS WIRE)--The "Global Small Molecule Contract Development and Manufacturing Organization (CDMO) Market Growth Opportunities, 2023" report has been added to ResearchAndMarkets.com's ...

BARCELONA, SPAIN – February 26, 2026 – ESTEVE CDMO, the global pure-play CDMO specializing in high-quality small-molecule APIs and pharmaceutical intermediates, today announced that it had commenced a ...

Teva announced its intention to divest its active-pharmaceutical ingredient business, or "TAPI". TAPI is a global leader in the small-molecule API industry, with approximately 4,300 employees ...

Raubling, Germany-based Axplora, which focuses on small-molecule API manufacturing reports that its total investments initiated across its global network in 2025 will exceed €100 million ($115.6 ...

Astorg, EQT, New Mountain Capital and TA Associates are among the PE firms buying and selling active pharmaceutical ingredient assets.

This month, the Joe Biden administration awarded $14 million to the API Innovation Center, a Saint Louis–based nonprofit that aims to remedy supply chain problems for active pharmaceutical ingredients ...